Want to join the conversation?
$LB raised its 2016 adjusted EPS guidance to range of $3.70-3.85 from previous forecast of $3.60-3.80. The company now expects EPS of $3.79-3.94, which includes a net $0.09 from year-to-date significant items. For 3Q16, the company expects EPS of $0.40-0.45.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?